AHA 2019: Results From The Treat Stroke To Target (TST) Trial — Prof Pierre Amarenco
- Видео
- О видео
- Скачать
- Поделиться
AHA 2019: Results From The Treat Stroke To Target (TST) Trial — Prof Pierre Amarenco
165 | 5 год. назад | 4 - 0
Prof Pierre Amarenco (Paris University, Paris, FR) discuss the Benefit of a Target LDL Cholesterol Less Than 70 mg/dl After an Ischemic Stroke of Atherosclerotic Origin
Questions :
1. Why was the TST trial conducted?
2. What was design, patient population and endpoints?
3. What were your findings?
4. How should this study influence clinical practice and guidelines?
5. Will TST influence further research in this field?
Filmed on site at AHA 2019 by Radcliffe Cardiology.
See more videos here :
RC Academy :
radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.
Чтобы скачать видео "AHA 2019: Results From The Treat Stroke To Target (TST) Trial — Prof Pierre Amarenco" передвинте ползунок вправо
- Комментарии
Комментарии ФБ